PERCUTANEOUS CORONARY AND VASCULAR INTERVENTIONS 

Panminerva Medica 2013 December;55(4):339-43

Copyright © 2014 EDIZIONI MINERVA MEDICA

lingua: Inglese

The optimal treatment of STEMI: new pharmacological and device approaches

Movahed M. R. ✉

CareMore Health Care Arizona, Division of Cardiology The Southern Arizona VA health Care System Tucson, Arizona and Division of Cardiology University of Arizona, Tucson, AZ, USA

Cardiovascular disease remains the leading cause of mortality worldwide. Many deaths are contributed to acute ST elevation myocardial infarction (STEMI). Recently, epidemiological studies have been shown reduction in STEMI related mortality over the last decade. This reduction has partially been attributed to new pharmacological and device advances that were utilized during STEMI treatment. The goal of this manuscript is to review new pharmacological and device approaches available in the treatment of STEMI patients.